Stockreport
Gilead Sciences stock jumps on HIV treatment trial success [Yahoo! Finance Canada]
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
results for its HIV treatment trial, claiming it's the first Phase 3 HIV prevention trial ever to show zero Infections. Market Domination Anchors Josh Lipton and Julie Hyman break down the latest development for Gilead Sciences and what it could mean for the company moving forward For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Nicholas Jacobino Video Transcript Now let's get to some trending tickers. First of Gilead Sciences. The shares of 8% after announcing that it's experimental twice yearly medicine to prevent HIV demonstrate demonstrated 100% efficacy for the investigation. Use in cisgender women in Africa, women and adolescent girls. So the company has some, um, medications on the market already. Um, but they either are daily oral. Or perhaps you have to do them as shots every months, so this is less frequent. So the hope is, is that this will be there will be more
[Read more]
IMPACT SNAPSHOT | EVENT TIME: | GILD | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GILD alerts
GILD alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
NEWS
NEWS
- Gilead Sciences (GILD) Stock Slides as Market Rises: Facts to Know Before You Trade [Yahoo! Finance][Yahoo! Finance]
- Gilead Sciences Recalls One Lot Of Its COVID-19 Treatment Due To Presence Of Glass Particles [Yahoo! Finance][Yahoo! Finance]
- IBBQ: This Low-Cost Biotech ETF Comes With Unique Risks [Seeking Alpha][Seeking Alpha]
- Gilead Sciences, Verizon Communications And ManpowerGroup Are Winners For Passive Income [Yahoo! Finance][Yahoo! Finance]
- High Growth Tech Stocks To Watch This September 2024 [Yahoo! Finance][Yahoo! Finance]
- More
GILD
SEC Filings
SEC Filings
- 9/13/24 - Form 4
- 9/13/24 - Form 4
- 9/12/24 - Form 144
- GILD's page on the SEC website
- More